Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 24, 2008

XDx to Restructure

  • XDx is reprioritizing its business efforts. The firm will increase its research, development, and commercial activities in support of AlloMap®. In addition, it will restructure its internal development program, pursue external research collaborations in lupus, as well as suspend development activities in lung transplant. A staff reduction of 25 positions and other cost-saving measures will be undertaken as well.


Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »